Kopula Konch Pharmaceutical Private Limited

Kopula Konch Pharmaceutical Private Limited - pharma in Gmc, Assam, India. Directors, charges & compliance details.
CIN U52599AS2022PTC022742 Incorporated 30 March 2022 ROC Guwahati HQ Gmc, Assam, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹29.77 Lakh
▲ 1164% YoY
Net profit · FY 2024
₹71,333
Net margin 2.4%
EBITDA · FY 2024
₹96,395
EBITDA margin 3.2%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹50,000
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Kopula Konch Pharmaceutical Private Limited

Data last updated:

Kopula Konch Pharmaceutical Private Limited is a private limited company based in Gmc, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 March 2022.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U52599AS2022PTC022742.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹50,000. It is led by directors including Sm Golam Mosabbir and Debajit Kumar Das.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gmc, Assam.

As per the financials filed for FY 2024, the company reported a revenue of ₹29.77 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹71,333 (net margin 2.4%) and EBITDA of ₹96,395 (EBITDA margin 3.2%).

Kopula Konch Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-03-0014259). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U52599AS2022PTC022742
Registration Number 022742
Incorporation Date 30 March 2022
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-AS-03-0014259
Key People
Nawaz Amania Islam Additional Director Sm Golam Mosabbir Director Debajit Kumar Das Director

Recognitions & Rankings of Kopula Konch Pharmaceutical

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-AS-03-0014259

Contact details

Kopula Konch Pharmaceutical Private Limited's registered office is in Gmc, Assam.

  • Registered Address
    House No 5 Suprabhat Path Notboma, Hatigaon Guwahati, Gmc, Assam, India – 781038
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Kopula Konch Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Kopula Konch Pharmaceutical is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Kopula Konch Pharmaceutical Private Limited, buy the company report.

Financials of Kopula Konch Pharmaceutical Private Limited

FY 2024 filings available

Kopula Konch Pharmaceutical Private Limited reported revenue of ₹29.77 Lakh (up 1164% YoY) for FY 2024.

Revenue · FY 2024
₹29.77 Lakh ▲ 1164%
Net profit · FY 2024
₹71,333 margin 2.4%
EBITDA · FY 2024
₹96,395 margin 3.2%

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹96,395
Profit Before Tax
Tax Expense
Net Profit (PAT)₹71,333
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin3.2%
Net Profit Margin2.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kopula Konch Pharmaceutical Private Limited, buy the company report.

Board of directors of Kopula Konch Pharmaceutical Private Limited

Kopula Konch Pharmaceutical has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nawaz Amania Islam
Also directs: Rizuwana Memorial Galaxy Womens Hospital LLP
Additional Director15 Jun 20224 Years 4 MonthsCurrent
Sm Golam MosabbirDirector30 Mar 20224 Years 7 MonthsCurrent
Debajit Kumar DasDirector30 Mar 20224 Years 7 MonthsCurrent
View all directors

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kopula Konch Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Kopula Konch Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Kopula Konch Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Nawaz Amania Islam was appointed as Additional Director on 15 Jun 2022.

AGM
Kopula Konch Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Kopula Konch Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati.
Appointed
Nawaz Amania Islam was appointed as Additional Director.
Appointed
Debajit Kumar Das was appointed as Director.
Appointed
Sm Golam Mosabbir was appointed as Director.
Incorporation
30 Mar 2022
Kopula Konch Pharmaceutical Private Limited was registered on 30 Mar 2022 with Roc Guwahati & aged 4 years 7 months as per MCA records.

Frequently asked questions

Kopula Konch Pharmaceutical is an active private limited company based in Gmc, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 March 2022 (4+ years old) and is registered under CIN U52599AS2022PTC022742.

Kopula Konch Pharmaceutical has 3 current directors:

The latest financial statements of Kopula Konch Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Kopula Konch Pharmaceutical is U52599AS2022PTC022742. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kopula Konch Pharmaceutical was incorporated on 30 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Guwahati.

Nawaz Amania Islam was appointed as Additional Director on 15 Jun 2022. Debajit Kumar Das was appointed as Director on 30 Mar 2022. Sm Golam Mosabbir was appointed as Director on 30 Mar 2022.

Yes, Kopula Konch Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-03-0014259).

The registered office of Kopula Konch Pharmaceutical is at House No 5 Suprabhat Path Notboma, Hatigaon Guwahati, Gmc, Assam, India – 781038.

Kopula Konch Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Kopula Konch Pharmaceutical is compliant as of 20 August 2026. The company is actively filing with the Registrar of Companies.